As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that policymakers set clear elimination targets for hepatitis B, coordinate efforts, enhance surveillance, and create supportive regulatory environments to support this.

For decades, newborns in the U.S. have been given the hepatitis B vaccine. This could change. A CDC vaccine advisory panel may vote to end that routine vaccination. Here's what parents should know.

The US Centers for Disease Control and Prevention (CDC) has awarded an unsolicited $1.6 million grant for vaccine research to a Danish university whose studies have been challenged by mainstream scientists but championed by anti-vaccine activists, including Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.

The CDC's vaccine advisory panel meets Thursday and Friday to discuss recommendations for the hepatitis B vaccine and the schedule of childhood shots.

The CDC has officially updated its immunization schedule to reflect its Advisory Committee on Immunization Practices’ recommendation on vaccinating infants against the hepatitis B virus, it announced.

Doctors say the controversial vote to not recommend the vaccine for all newborns is creating chaos and hurdles for parents.

Four of the top medical leaders in Virginia have signed a letter opposing a vote last week by a Centers for Disease Control committee to end the agency’s recommendation for universal hepatitis B vaccines for all newborns at birth.

The best way to prevent hepatitis B infection is vaccination. The vaccines are highly effective at preventing infection in infants and for long-term protection into adulthood.